Crown Letter: Dr. Alex Oshmyansky

Dear Dr. Oshmyansky,

You’ve already proven that transparent pricing in pharmaceuticals isn’t just possible — it’s profitable. Cost Plus Drug Company demonstrated that you can sell medications at cost plus a small margin and still build a sustainable business.

We want to take that model further.

The Invitation

We’re inviting you to lead LifeLine Medications — our pharmaceutical access initiative within Liana Banyan.

What LifeLine Medications Does

How It Integrates

LifeLine Medications connects to:

• LB MSA — Medical Savings Accounts for payment
• VSL — Microloans for medication costs
• The Family Table — Nutrition as medicine
• Tatiana Schlossburg Health Accords — Preventive care

Why You

You’ve already done the hard part — proving the model works.

What You’ve Demonstrated

• Transparent pricing is sustainable
• Customers respond to honesty
• The pharmaceutical industry’s margins are indefensible
• Technology can disintermediate gatekeepers

What We’re Asking

• Apply that same model within an integrated platform
• Connect medication access to the broader support system
• Help design the LifeLine Medications architecture
• Advise on regulatory navigation

You don’t have to leave Cost Plus. You can do both.

The Economics

Cost+20% applies to everything in Liana Banyan — including medications.

The Math

The Volume Play

With 1 million members at $5/year:

• $5M annual membership revenue
• Bulk purchasing power for better wholesale prices
• Predictable demand for inventory planning
• Direct relationships with manufacturers

The Integration

LifeLine Medications doesn’t stand alone — it’s part of an interconnected system.

The Flow

Member needs medication
        ↓
LifeLine Medications finds lowest cost
        ↓
LB MSA provides payment method
        ↓
VSL provides microloan if needed
        ↓
Member gets medication at cost+20%

The Support Network

The Ask

We’re not asking you to abandon what you’ve built. We’re asking you to extend it.

Specifically

1. Advisory Role — Help design LifeLine Medications architecture
2. Regulatory Guidance — Navigate FDA, state pharmacy boards
3. Network Access — Connect to your manufacturer relationships
4. Credibility — Your name validates the approach

Compensation

• Crown Jewel equity position in Liana Banyan
• Advisory fees at market rate
• No exclusivity — continue your other work
• Impact — reach populations Cost Plus can’t currently serve

The Vision

Imagine a world where:

• Medication cost is never the reason someone doesn’t get treatment
• Price transparency is the default, not the exception
• Generic access is universal, not privileged
• The pharmacy industry’s margins are exposed and eliminated

You’ve started this. We want to help you finish it.

Next Steps

If this resonates, let’s talk.

No commitment required — just a conversation about:

• What LifeLine Medications could look like
• How it would integrate with your existing work
• What resources you’d need
• What concerns you’d have

Contact

Founder, Liana Banyan Corporation

• Platform: lianabanyan.com
• Documentation: cephas.lianabanyan.com